| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 19/12/2008 | 15:45 | Business Wire | ONI BioPharma to Commence Trading on the Over-the-Counter Bulletin Board on Monday, December 22, 2008; ONI BioPharma to Post ... | AMEX:ONI | Oragenics, |
| 16/12/2008 | 12:01 | Edgar (US Regulatory) | Current report filing (8-K) | AMEX:ONI | Oragenics, |
| 05/12/2008 | 19:33 | Marketwired | ONI BioPharma Announces Proposed Rights Offering to Shareholders | AMEX:ONI | Oragenics, |
| 04/11/2008 | 22:11 | Edgar (US Regulatory) | Quarterly Report (10-Q) | AMEX:ONI | Oragenics, |
| 31/10/2008 | 22:36 | Marketwired | ONI BioPharma Inc. Offers Investor Update. Topics Include: (1) Appeal of American Stock Exchange Delisting Decision, (2) Operat | AMEX:ONI | Oragenics, |
| 16/10/2008 | 16:55 | Marketwired | ONI BioPharma Inc. Announces Latin American Affiliate | AMEX:ONI | Oragenics, |
| 14/10/2008 | 22:30 | Marketwired | ONI BioPharma Inc. Announces Successful Antibiotic Synthesis Using DPOLT(TM) Technology | AMEX:ONI | Oragenics, |
| 02/10/2008 | 23:04 | Edgar (US Regulatory) | Oragenics Inc - Current report filing (8-K) | AMEX:ONI | Oragenics, |
| 29/09/2008 | 23:46 | Marketwired | ONI BioPharma Inc. Licenses Unique Gene Targets for Colorectal Cancer | AMEX:ONI | Oragenics, |
| 26/09/2008 | 21:38 | Marketwired | ONI BioPharma Inc. Launches the ProBiora3(TM) Website | AMEX:ONI | Oragenics, |
| 18/09/2008 | 22:42 | Marketwired | ONI BioPharma Inc. Commences Market Launch of Unique Oral Probiotic Product | AMEX:ONI | Oragenics, |
| 14/08/2008 | 21:15 | Edgar (US Regulatory) | Oragenics Inc - Quarterly Report (10-Q) | AMEX:ONI | Oragenics, |
| 08/07/2008 | 16:42 | Edgar (US Regulatory) | Oragenics Inc - Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:ONI | Oragenics, |
| 07/07/2008 | 20:53 | Edgar (US Regulatory) | Oragenics Inc - Initial Statement of Beneficial Ownership (3) | AMEX:ONI | Oragenics, |
| 01/07/2008 | 22:32 | Marketwired | ONI BioPharma Appoints New Chief Operational Officer | AMEX:ONI | Oragenics, |
| 25/06/2008 | 18:02 | Marketwired | American Stock Exchange Accepts ONI BioPharma Inc.'s Revised Plan of Compliance | AMEX:ONI | Oragenics, |
| 13/06/2008 | 17:40 | Edgar (US Regulatory) | Oragenics Inc - Amended Statement of Changes in Beneficial Ownership (4/A) | AMEX:ONI | Oragenics, |
| 13/06/2008 | 15:00 | Marketwired | ONI BioPharma Inc. Announces Closing on $2,600,000 in Equity Financing | AMEX:ONI | Oragenics, |
| 12/06/2008 | 23:08 | Edgar (US Regulatory) | Oragenics Inc - Statement of Changes in Beneficial Ownership (4) | AMEX:ONI | Oragenics, |
| 02/06/2008 | 15:00 | Marketwired | ONI BioPharma Inc. Announces Definitive Term Sheet for $2,600,000 in Equity Financing | AMEX:ONI | Oragenics, |
| 16/05/2008 | 21:00 | Marketwired | Oragenics, Inc. (ONI BioPharma Inc.) Receives Notification Letter From American Stock Exchange | AMEX:ONI | Oragenics, |
| 13/05/2008 | 15:00 | Marketwired | Oragenics, Inc. Changes Name to ONI Biopharma Inc. | AMEX:ONI | Oragenics, |
| 09/05/2008 | 16:11 | Marketwired | Oragenics Announces Test Marketing of Probiora3(TM) Chewable Tablets | AMEX:ONI | Oragenics, |
| 07/05/2008 | 22:28 | Edgar (US Regulatory) | Oragenics Inc - Securities Registration: Employee Benefit Plan (S-8) | AMEX:ONI | Oragenics, |
| 28/04/2008 | 15:53 | Marketwired | Dr. Marc Siegel and Kevin Sills Join Oragenics' Board of Directors | AMEX:ONI | Oragenics, |
| 18/03/2008 | 13:50 | Edgar (US Regulatory) | Oragenics Inc - Annual Report (Small Business Issuers) (10KSB) | AMEX:ONI | Oragenics, |
| 18/03/2008 | 13:01 | Edgar (US Regulatory) | Oragenics Inc - Proxy Statement (definitive) (DEF 14A) | AMEX:ONI | Oragenics, |
| 03/03/2008 | 19:12 | Marketwired | Oragenics, Inc. Announces the Early Exercise of Warrants | AMEX:ONI | Oragenics, |
| 19/02/2008 | 15:00 | Marketwired | Oragenics, Inc. Wins $0.5 Million Phase II SBIR Grant for Its Unique Antibiotic Technology | AMEX:ONI | Oragenics, |
| 12/02/2008 | 21:44 | Marketwired | Oragenics Announces the Exercise of Warrants and a Management Change | AMEX:ONI | Oragenics, |